Advertisement
Advertisement

CNXU

CNXU logo

Conexeu Sciences Inc. Common Stock

8.07
USD
Sponsored
-0.40
-4.72%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

8.00

-0.08
-0.93%

Conexeu Sciences Inc. Common Stock Profile

About

Conexeu Sciences Inc. is a preclinical-stage regenerative tissue platform company. Its lead product include Ten Minute Tissue(TM), is a CXU-based injectable ECM that remains fluid at room temperature and transitions to a stable gel in situ at body temperature. Conexeu Sciences Inc. is based in Reno, Nevada.

Info & Links

CEO

Miles Harrison

Headquarters

50 WEST LIBERTY STREET, SUITE 880
RENO, NV 89501, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.conexeu.com

Auditor

Adeptus Partners, LLC

Share holders

--

Employees

--

Conexeu Sciences Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

213.93M

Enterprise Value

206.63M

Enterprise Value/EBITDA(ttm)

-50.58

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

28.34

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-57.20%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-4.09M

Net Income Available to Common(ttm)

-4.02M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

--

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

26.76M

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

7.30M

Total Cash Per Share(mrq)

0.27

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

14.93%

Quick Ratio(mrq)

14.93%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.16

Free Cash Flow(ytd)

-3.38M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement